{"id":48473,"date":"2024-07-22T17:49:50","date_gmt":"2024-07-22T16:49:50","guid":{"rendered":"https:\/\/www.btitrainingcenter.com\/plasma-rich-in-growth-factors-prgf-technology-as-adjuvant-to-ab-externo-trabeculectomy\/"},"modified":"2026-04-20T12:24:54","modified_gmt":"2026-04-20T11:24:54","slug":"plasma-rich-in-growth-factors-prgf-technology-as-adjuvant-to-ab-externo-trabeculectomy","status":"publish","type":"post","link":"https:\/\/www.btitrainingcenter.com\/de\/plasma-rich-in-growth-factors-prgf-technology-as-adjuvant-to-ab-externo-trabeculectomy\/","title":{"rendered":"Plasma rich in growth factors (PRGF) technology as adjuvant to Ab Externo trabeculectomy"},"content":{"rendered":"

[vc_row content_text_aligment=”left” row_background_lines=”no”][vc_column][vc_column_text css=””]<\/p>\n

Abstract<\/h3>\n
\n
\n

Purpose:\u00a0<\/strong>Plasma rich in growth factors (PRGF) technology creates blood-derived products with growth factors that promote wound healing and regeneration. The goal of this study was to assess the potential role of PRGF products as wound modulators in trabeculectomy. Our premise is that due to PRGF’s regenerative and antifibrotic properties, its use in trabeculectomy may produce a more physiological bleb, without altering IOP reduction.<\/p>\n<\/div>\n

Methods:\u00a0<\/strong>A retrospective, longitudinal study was conducted in a Hospital in Portugal. Patients with eyes with open angle glaucoma were included. Trabeculectomy was performed on all patients using PRGF membrane (mPRGF) under the conjunctiva, as adjuvant. Data regarding patients’ demographics and number of medications used, was collected. Intraocular pressure (IOP) before surgery, 8 days, 1 month, 3 month, 6 month, 9 month and 1 year after surgery was recorded. Bleb morphology was classified according to Moorfields Bleb Grading System 6 months after surgery.<\/p>\n

Results:\u00a0<\/strong>Nine eyes of 9 patients were enrolled. Mean age was 71 \u00b1 5.1 years old. Six were male. Mean IOP decreased from 24.0 \u00b1 8.8 mmHg pre-surgery to 12.9 \u00b1 2.6 mmHg at one year follow-up. The number of hypotensive drugs (mean \u00b1 SD) was 4.3 \u00b1 0.9 preoperatively and 0.8 \u00b1 1.1 at 1-year. Complete success was defined as IOP equal to or less than 21 mm Hg without ocular hypotensive medications and qualified success as IOP equal to or less than 21 mm Hg with medications. Complete success was 66.7% and qualified success was 100% at 1 year follow-up.<\/p>\n

Conclusions:\u00a0<\/strong>In our study, trabeculectomy with mPRGF demonstrated both safety and efficacy. Low values of bleb height (1.6 \u00b1 0.8) were recorded. mPRGF could improve wound healing and produce a more well-tolerated, favourable bleb, avoiding antimetabolite complications.<\/p>\n<\/div>\n

Keywords:\u00a0<\/strong>Antimetabolite; Bleb; PRGF; Trabeculectomy.<\/p>\n

[\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column]\n Zum vollst\u00e4ndigen Artikel<\/span>\n <\/a>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Int Ophthalmol. 2024 Jul 22;44(1):332.<\/strong>
\nPlasma rich in growth factors (PRGF) technology creates blood-derived products with growth factors that promote wound healing and regeneration. The goal of this study was to assess the potential role of PRGF products as wound modulators in trabeculectomy. Our premise is that due to PRGF’s regenerative and antifibrotic properties, its use in trabeculectomy may produce a more physiological bleb, without altering IOP reduction.<\/p>\n","protected":false},"author":2002,"featured_media":48442,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[156],"tags":[],"class_list":["post-48473","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regenerative-medizin"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/posts\/48473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/users\/2002"}],"replies":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/comments?post=48473"}],"version-history":[{"count":1,"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/posts\/48473\/revisions"}],"predecessor-version":[{"id":48474,"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/posts\/48473\/revisions\/48474"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/media\/48442"}],"wp:attachment":[{"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/media?parent=48473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/categories?post=48473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.btitrainingcenter.com\/de\/wp-json\/wp\/v2\/tags?post=48473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}